<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 3.4: The Insulin-Androgen Connection | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

.patient-avatar {
 width: 56px;
 height: 56px;
 background: linear-gradient(135deg, #fecaca, #fca5a5);
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 28px;
 flex-shrink: 0;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}

.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
 counter-reset: ref-counter;
}

.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 line-height: 1.7;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}

.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

/* MODULE CONNECTION */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-icon {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #0ea5e9, #0284c7);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 flex-shrink: 0;
}

.module-connection .connection-text {
 flex: 1;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
 line-height: 1.5;
}

 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 3: Stabilizing Metabolic Foundations</span>
 <h1 class="lesson-title">The Insulin-Androgen Connection: Mechanisms of PCOS</h1>
 <div class="lesson-meta">
 <span class="meta-badge"><span class="icon">‚è±Ô∏è</span> 14 min read</span>
 <span class="meta-badge"><span class="icon">üéì</span> Lesson 4 of 8</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Excellence</div>
 <div class="title">AccrediPro Standards Institute‚Ñ¢ Certified Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#theca-cells"><span class="section-num">01</span>The Theca Cell Axis</a></li>
 <li><a href="#shbg-gatekeeper"><span class="section-num">02</span>SHBG: The Gatekeeper</a></li>
 <li><a href="#pituitary-lh"><span class="section-num">03</span>The Pituitary Disconnect</a></li>
 <li><a href="#follicular-arrest"><span class="section-num">04</span>Follicular Arrest</a></li>
 <li><a href="#pcos-phenotypes"><span class="section-num">05</span>Clinical Phenotypes</a></li>
 <li><a href="#restore-application"><span class="section-num">06</span>The R.E.S.T.O.R.E. Protocol</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>In the previous lessons, we established that <strong>blood sugar stability</strong> is the bedrock of hormonal health. Now, we examine the most common clinical manifestation of metabolic-endocrine dysfunction: <strong>Polycystic Ovary Syndrome (PCOS)</strong>.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome, Practitioner</h3>
 <p>PCOS is often misunderstood as a "ovary problem," but as a Hormone Health Specialist, you will recognize it as a <strong>metabolic-endocrine feedback loop</strong>. In this lesson, we will deconstruct the elegant but destructive biochemistry that links high insulin to excess androgens. Understanding these mechanisms allows you to offer your clients more than just a birth control prescription; you offer them a <em>functional resolution</em>.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Identify the biochemical pathway by which hyperinsulinemia stimulates ovarian theca cells.</li>
 <li>Explain how insulin suppresses Sex Hormone Binding Globulin (SHBG) and increases free testosterone.</li>
 <li>Analyze the impact of insulin on the HPO axis, specifically the LH/FSH ratio.</li>
 <li>Differentiate between the four clinical phenotypes of PCOS using the Rotterdam Criteria.</li>
 <li>Formulate a metabolic-first intervention strategy using the R.E.S.T.O.R.E. framework.</li>
 </ul>
 </div>

 <h2 id="theca-cells">The Theca Cell Overdrive: Insulin as a Co-Gonadotropin</h2>
 <p>In a healthy cycle, the ovaries respond to Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). However, the ovaries are also highly sensitive to <strong>insulin</strong>. When a woman develops hyperinsulinemia (high insulin), the insulin acts as a "co-gonadotropin."</p>
 
 <p>Insulin binds to receptors on the <strong>theca cells</strong> of the ovaries. These cells are responsible for producing androstenedione, a precursor to testosterone. Under the influence of high insulin, theca cells become hyper-responsive, overproducing androgens. This is a direct metabolic-to-hormonal conversion that bypasses the brain's normal regulatory signals.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Explaining to Clients</span>
 <p>Think of insulin like a megaphone. In small amounts, it helps the ovaries hear the brain's instructions. But when insulin is too high, it's like shouting through a megaphone directly into the ovaries, causing them to "panic" and overproduce testosterone.</p>
 </div>

 <h2 id="shbg-gatekeeper">SHBG: The Gatekeeper of Free Testosterone</h2>
 <p>Hormones in the blood do not travel alone; they are usually bound to "carrier" proteins. <strong>Sex Hormone Binding Globulin (SHBG)</strong> is the primary carrier for testosterone. When testosterone is bound to SHBG, it is inactive‚Äîit cannot enter cells to cause acne, hair loss, or facial hair growth.</p>

 <p>High insulin sends a direct signal to the liver to <strong>downregulate the production of SHBG</strong>. This creates a "double whammy" effect:</p>
 <ul>
 <li><strong>Step 1:</strong> High insulin tells the ovaries to make <em>more</em> testosterone.</li>
 <li><strong>Step 2:</strong> High insulin tells the liver to make <em>less</em> SHBG to carry it.</li>
 </ul>
 <p>The result is a significant increase in <span class="highlight">Free Testosterone</span>‚Äîthe biologically active form that drives PCOS symptoms. This is why a client may have "normal" total testosterone on a lab report but still suffer from severe androgenic symptoms.</p>

 <h2 id="pituitary-lh">The Pituitary Disconnect: LH/FSH Ratios</h2>
 <p>The metabolic chaos of insulin doesn't stop at the ovaries; it reaches the <strong>pituitary gland</strong> in the brain. High insulin increases the pulse frequency of Gonadotropin-Releasing Hormone (GnRH). This rapid pulsing favors the production of <strong>Luteinizing Hormone (LH)</strong> over <strong>Follicle-Stimulating Hormone (FSH)</strong>.</p>

 <p>In a functional assessment, we often see an <strong>LH:FSH ratio of 2:1 or 3:1</strong>. Because FSH is too low relative to LH, the follicles are never given the signal to fully mature and release an egg. This leads to the hallmark of PCOS: <strong>anovulation</strong> (lack of ovulation).</p>

 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë©‚Äçüíº</div>
 <div>
 <p class="title">Case Study: Sarah, 44</p>
 <p class="subtitle">The Perimenopausal PCOS Pivot</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <div class="patient-avatar">S</div>
 <div class="patient-info">
 <h4>Sarah, 44 Years Old</h4>
 <p>Former Nurse | Weight Gain + Adult Acne</p>
 </div>
 </div>
 <p>Sarah presented with a 15lb weight gain around her midsection, chin hair (hirsutism), and cycles that had stretched from 28 days to 45 days. Her GP told her it was "just perimenopause."</p>
 <p><strong>Functional Findings:</strong> Sarah's Fasting Insulin was 18 ¬µIU/mL (Optimal is &lt;5). Her SHBG was low (22 nmol/L). Her LH was 14 mIU/mL while her FSH was only 5 mIU/mL. Sarah didn't just have perimenopause; she had <strong>Insulin-Resistant PCOS</strong> that was being exacerbated by the natural decline of progesterone in her 40s.</p>
 <p><strong>Outcome:</strong> By focusing on the <strong>Metabolic Foundation</strong> (R.E.S.T.O.R.E. Phase S), Sarah stabilized her insulin. Within 4 months, her cycles normalized to 30 days, her acne cleared, and she lost 12lbs without restrictive dieting.</p>
 </div>
 </div>

 <h2 id="follicular-arrest">Follicular Arrest: Why Ovulation Stops</h2>
 <p>The "cysts" seen on an ultrasound in PCOS are not actually cysts in the traditional sense. They are <strong>immature follicles</strong> that have stopped growing‚Äîa state known as <strong>follicular arrest</strong>.</p>
 
 <p>Because the androgens (testosterone) are so high inside the ovary, they create a "toxic" environment for the developing egg. The high levels of insulin and LH cause the outer layer of the follicle to thicken (theca hyperplasia), making it physically difficult for an egg to be released even if it did mature. This results in the "string of pearls" appearance on an ultrasound.</p>

 <h2 id="pcos-phenotypes">The Four Phenotypes of PCOS</h2>
 <p>It is a common mistake to assume all PCOS clients are the same. Using the <strong>Rotterdam Criteria</strong>, we categorize PCOS into four distinct phenotypes. This is critical for your practice, as the intervention for Type A is very different from Type D.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Phenotype</th>
 <th>Clinical Features</th>
 <th>Metabolic Profile</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Type A (Classic)</strong></td>
 <td>High Androgens + No Ovulation + Polycystic Ovaries</td>
 <td>Highest risk for severe insulin resistance.</td>
 </tr>
 <tr>
 <td><strong>Type B (Hyperandrogenic)</strong></td>
 <td>High Androgens + No Ovulation</td>
 <td>Significant metabolic dysfunction; ovaries may look normal.</td>
 </tr>
 <tr>
 <td><strong>Type C (Ovulatory)</strong></td>
 <td>High Androgens + Polycystic Ovaries</td>
 <td>Often "Lean PCOS"; milder insulin resistance.</td>
 </tr>
 <tr>
 <td><strong>Type D (Non-Androgenic)</strong></td>
 <td>No Ovulation + Polycystic Ovaries</td>
 <td>Often driven by stress (HPA axis) or post-pill transition.</td>
 </tr>
 </tbody>
 </table>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The "Lean PCOS" Myth</span>
 <p>Don't assume a thin client doesn't have insulin resistance. "Lean PCOS" (often Type C) can still involve high post-prandial insulin spikes that drive androgen production, even if their Fasting Glucose looks "perfect."</p>
 </div>

 <h2 id="restore-application">The R.E.S.T.O.R.E. Clinical Application</h2>
 <p>When working with a PCOS client, we always start with the <strong>"S" (Stabilizing Metabolic Foundations)</strong>. If you try to fix the androgens without fixing the insulin, you are mopping the floor while the sink is still overflowing.</p>

 <div class="principles-grid">
 <div class="principle-card">
 <div class="principle-number">1</div>
 <div class="principle-content">
 <p class="principle-title">Lower the Insulin "Volume"</p>
 <p class="principle-text">Use the glycemic variability strategies from Lesson 3.2 to reduce the "shouting" at the theca cells.</p>
 </div>
 </div>
 <div class="principle-card">
 <div class="principle-number">2</div>
 <div class="principle-content">
 <p class="principle-title">Support the Liver (SHBG)</p>
 <p class="principle-text">Address Phase I and II detoxification to help the liver resume SHBG production and clear excess androgens.</p>
 </div>
 </div>
 <div class="principle-card">
 <div class="principle-number">3</div>
 <div class="principle-content">
 <p class="principle-title">Optimize the HPO Axis</p>
 <p class="principle-text">Reduce stress and inflammation to slow GnRH pulsing, allowing FSH to rise and LH to stabilize.</p>
 </div>
 </div>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <p class="question-text"><strong>1. How does insulin act as a "co-gonadotropin" in the ovaries?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Insulin binds to receptors on the theca cells, stimulating them to overproduce androgens (like testosterone) independently of or in synergy with LH.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>2. Why is SHBG important in PCOS, and how does insulin affect it?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">SHBG binds to testosterone to make it inactive. High insulin suppresses SHBG production in the liver, leading to higher levels of "Free Testosterone," which causes symptoms like acne and hirsutism.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>3. What is the classic LH:FSH ratio often seen in PCOS clients?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">A ratio of 2:1 or 3:1 (LH is significantly higher than FSH), which prevents follicles from maturing and releasing an egg.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>4. True or False: A woman must have polycystic ovaries on an ultrasound to be diagnosed with PCOS.</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">False. Under the Rotterdam Criteria, a woman only needs 2 out of 3 symptoms: High androgens, Irregular/No ovulation, or Polycystic ovaries. (Phenotype B has no cysts).</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>Insulin is a Primary Driver:</strong> Hyperinsulinemia is the "root of the root" for the majority of PCOS cases.</li>
 <li><strong>The Double Whammy:</strong> Insulin increases testosterone production while simultaneously decreasing the protein (SHBG) that keeps it in check.</li>
 <li><strong>Follicular Arrest:</strong> High androgens and high LH prevent the normal maturation of eggs, leading to infertility and irregular cycles.</li>
 <li><strong>Biochemical Individuality:</strong> PCOS presents in four different phenotypes; identifying the phenotype is essential for targeted coaching.</li>
 <li><strong>Metabolic-First:</strong> Successful PCOS resolution requires stabilizing insulin before attempting to "balance" sex hormones directly.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Dunaif, A. (2021). "Insulin Resistance and the Polycystic Ovary Syndrome Revisited." <em>Endocrine Reviews</em>.</li>
 <li>Moghetti, P. et al. (2020). "Insulin Resistance and PCOS: A Systematic Review." <em>Journal of Clinical Endocrinology & Metabolism</em>.</li>
 <li>Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004). "Revised consensus on diagnostic criteria and long-term health risks related to PCOS." <em>Fertility and Sterility</em>.</li>
 <li>Nestler, J. E. (1997). "Insulin regulation of human ovarian androgens." <em>Human Reproduction</em>.</li>
 <li>Wang, J. et al. (2019). "Hyperinsulinemia and theca cell hyperresponsiveness in PCOS." <em>Molecular and Cellular Endocrinology</em>.</li>
 <li>Azziz, R. et al. (2016). "The Polycystic Ovary Syndrome." <em>Nature Reviews Disease Primers</em>.</li>
 </ol>
 </div>
</div>

<script>
document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
});
</script>
</body>
</html>